Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Got $500? 2 Compelling Growth Stocks to Buy and Hold Forever


Great companies can deliver meaningful portfolio growth in a wide range of economic and market environments. From established companies to emerging businesses, the types of stocks you favor will depend on numerous factors, including your personal financial goals, risk tolerance level, and investment style.

If you're looking for compelling growth stocks and have $500 to invest right now, here are two names to consider the next time you add to your buy basket.

Vertex Pharmaceuticals (NASDAQ: VRTX) has a virtually unchallenged position on a lucrative segment of the rare disease drug market. The company is the only one to have commercialized drugs on the market that treat the underlying root cause of the genetic ailment cystic fibrosis. This portfolio of drugs, known formally as cystic fibrosis transmembrane conductance regulator (CFTR) modulators, are led by the company's flagship therapy, Trikafta.

Continue reading


Source Fool.com

Vertex Pharmaceuticals Inc. Stock

€431.00
1.060%
There is an upward development for Vertex Pharmaceuticals Inc. compared to yesterday, with an increase of €4.50 (1.060%).
With 60 Buy predictions and 2 Sell predictions Vertex Pharmaceuticals Inc. is one of the favorites of our community.
As a result the target price of 440 € shows a slightly positive potential of 2.09% compared to the current price of 431.0 € for Vertex Pharmaceuticals Inc..
Like: 0
Share

Comments